These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1113 related articles for article (PubMed ID: 33766185)

  • 1. SARS-CoV-2 re-infection: development of an epidemiological definition from India.
    Mukherjee A; Anand T; Agarwal A; Singh H; Chatterjee P; Narayan J; Rana S; Gupta N; Bhargava B; Panda S
    Epidemiol Infect; 2021 Mar; 149():e82. PubMed ID: 33766185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The symptoms and interval of Omicron SARS-CoV-2 reinfection among healthcare workers in a hospital of Southern China: a cross-sectional study.
    Ma X; Wang Z; Chen Y; Li Z
    BMC Infect Dis; 2024 Mar; 24(1):354. PubMed ID: 38539124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with asymptomatic infection in health-care workers with severe acute respiratory syndrome coronavirus 2 infection in Wuhan, China: a multicentre retrospective cohort study.
    Zhang S; Guo M; Wu F; Xiong N; Ma Y; Wang Z; Duan L; Chen L; Ouyang H; Jin Y
    Clin Microbiol Infect; 2020 Dec; 26(12):1670-1675. PubMed ID: 32911080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Post-Infection Protection after COVID-19 among Healthcare Workers: A Population-Level Observational Study.
    Shahriarirad S; Asmarian N; Shahriarirad R; Moghadami M; Askarian M; Hashemizadeh Fard Haghighi L; Javadi P; Sabetian G
    Iran J Med Sci; 2024 Apr; 49(4):247-258. PubMed ID: 38680224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-infection of malaria and early clearance of SARS-CoV-2 in healthcare workers.
    Mahajan NN; Gajbhiye RK; Bahirat S; Lokhande PD; Mathe A; Rathi S; Warty N; Mahajan KN; Srivastava V; Kuppusamy P; Mohite SC
    J Med Virol; 2021 Apr; 93(4):2431-2438. PubMed ID: 33368412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).
    Hall VJ; Foulkes S; Charlett A; Atti A; Monk EJM; Simmons R; Wellington E; Cole MJ; Saei A; Oguti B; Munro K; Wallace S; Kirwan PD; Shrotri M; Vusirikala A; Rokadiya S; Kall M; Zambon M; Ramsay M; Brooks T; Brown CS; Chand MA; Hopkins S;
    Lancet; 2021 Apr; 397(10283):1459-1469. PubMed ID: 33844963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral Shedding among Re-Positive Severe Acute Respiratory Syndrome Coronavirus-2 Positive Individuals in Republic of Korea.
    Kim JM; Ryu B; Choe YJ; Jo HJ; Lee H; Kim HM; Lee NJ; Rhee JE; Chung YS; Han MG; Kim EJ; Park Y; Gwack J; Jin Y; Song J; Seo S; Gill B; Kim H; Park Y; Yoo CK; Jeong EK
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of epidemiological and clinical characteristics of people infected with SARS-CoV-2 during the second pandemic of COVID-19 in Chengdu, China.
    Li C; Zhou T; Zhang P; He J; Liu Y
    Front Public Health; 2024; 12():1394762. PubMed ID: 38756875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and frequency of COVID-19 among healthcare workers at a tertiary care centre in India: a case-control study.
    Dev N; Meena RC; Gupta DK; Gupta N; Sankar J
    Trans R Soc Trop Med Hyg; 2021 May; 115(5):551-556. PubMed ID: 33763687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2.
    Sharma R; Sardar S; Mohammad Arshad A; Ata F; Zara S; Munir W
    Am J Case Rep; 2020 Dec; 21():e927154. PubMed ID: 33257644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 infection in asymptomatic healthcare workers at a clinic in Chile.
    Olmos C; Campaña G; Monreal V; Pidal P; Sanchez N; Airola C; Sanhueza D; Tapia P; Muñoz AM; Corvalan F; Hurtado S; Meneses C; Orellana A; Montecino M; Arriagada G; Bustos FJ
    PLoS One; 2021; 16(1):e0245913. PubMed ID: 33507981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 re-infection risk in Austria.
    Pilz S; Chakeri A; Ioannidis JP; Richter L; Theiler-Schwetz V; Trummer C; Krause R; Allerberger F
    Eur J Clin Invest; 2021 Apr; 51(4):e13520. PubMed ID: 33583018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete Analysis of the Epidemiological Scenario around a SARS-CoV-2 Reinfection: Previous Infection Events and Subsequent Transmission.
    Pérez Lago L; Pérez Latorre L; Herranz M; Tejerina F; Sola-Campoy PJ; Sicilia J; Suárez-González J; Andrés-Zayas C; Chiner-Oms A; Jiménez-Serrano S; García-González N; Comas I; González-Candelas F; Martínez-Laperche C; Catalán P; Muñoz P; García de Viedma D;
    mSphere; 2021 Oct; 6(5):e0059621. PubMed ID: 34494886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary SARS-CoV-2 Infections, Re-infections and Vaccine Effectiveness during the Omicron Transmission Period in Healthcare Workers of Trieste and Gorizia (Northeast Italy), 1 December 2021-31 May 2022.
    Cegolon L; Negro C; Mastrangelo G; Filon FL;
    Viruses; 2022 Nov; 14(12):. PubMed ID: 36560692
    [No Abstract]   [Full Text] [Related]  

  • 15. Previous SARS-CoV-2 Infection Status Among the Current RT-PCR-Positive Individuals Affected During the Second Wave of COVID-19 Infections in Chennai, India.
    Thangaraj JWV; Kumar MS; Kumar CPG; Yadav P; Rani DS; Karunakaran T; Murhekar M
    Front Public Health; 2022; 10():836454. PubMed ID: 35444976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological and clinical characteristics of COVID-19 reinfection during the epidemic period in Yangzhou city, Jiangsu province.
    Wang Y; Liang J; Yang H; Zhu L; Hu J; Xiao L; Huang Y; Dong Y; Wu C; Zhang J; Zhou X
    Front Public Health; 2023; 11():1256768. PubMed ID: 37780420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymptomatic infection by SARS-CoV-2 in healthcare workers: A study in a large teaching hospital in Wuhan, China.
    Zhao D; Wang M; Wang M; Zhao Y; Zheng Z; Li X; Zhang Y; Wang T; Zeng S; Hu W; Yu W; Hu K
    Int J Infect Dis; 2020 Oct; 99():219-225. PubMed ID: 32758693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Presentation of Cases with SARS-CoV-2 Reinfection/ Reactivation.
    Mahajan NN; Gajbhiye RK; Lokhande PD; Bahirat S; Modi D; Mathe AM; Bharmal R; Rathi S; Mohite SC; Tilve A
    J Assoc Physicians India; 2021 Jan; 69(1):16-18. PubMed ID: 34227769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.